Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gisselbrecht

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
La Revue De Medecine Interne|January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults. Principles, realization, and application to the treatment of germinal, trophoblastic, breast, ovarian and small-cell bronchial tumors. 2]J P Lotz, F Pene, C Bouleuc, et al.
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Blood|July 15, 1992
Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patientsD Emilie, J Coumbaras, M Raphael, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
The FAM regimen for gastric cancer: a progress reportP S Schein, J S Macdonald, P V Woolley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)T Philip, F Chauvin, D Bron, et al.
The American Journal of Pathology|October 1, 1993
Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latencyS J Hamilton-Dutoit, D Rea, M Raphael, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
La Revue De Medecine Interne|January 1, 1995
[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults. Principles, realization, and application to the treatment of germinal, trophoblastic, breast, ovarian and small-cell bronchial tumors. 2]J P Lotz, F Pene, C Bouleuc, et al.
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Blood|July 15, 1992
Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patientsD Emilie, J Coumbaras, M Raphael, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
The FAM regimen for gastric cancer: a progress reportP S Schein, J S Macdonald, P V Woolley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)T Philip, F Chauvin, D Bron, et al.
The American Journal of Pathology|October 1, 1993
Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latencyS J Hamilton-Dutoit, D Rea, M Raphael, et al.
Pageof 22